Beginning sexual activity at an early age and multiple sexual partners are risk factors for HPV infection.
There is a recent study that is the first to validate surveys where young women say they do not plan to modify their sexual behaviors after HPV vaccination.
“Some have suggested the HPV vaccine might be a license for sexual activity,” said Robert Bednarczyk, PhD, an epidemiologist and the study’s lead author. This has been found not to be the case.
Many HPV Vaccine Concerns Unfounded
Featuring:
Nicola P. Klein, MD, PhD, is a research scientist at the Kaiser Permanente Northern California Division of Research; co-director of the Kaiser Permanente Vaccine Study Center; and clinical instructor in the Department of Pediatrics, Lucile Salter Packard Children’s Hospital at Stanford, Stanford University School of Medicine. Dr. Klein received her medical and doctorate degrees at New York University School of Medicine.
Robert A. Bednarczyk, PhD, is a Clinical Investigator with Kaiser Permanente Center for Health Research – Southeast and an Epidemiologist with the Hubert Department of Global Health, Rollins School of Public Health, Emory University. Dr. Bednarczyk completed his PhD in infectious disease epidemiology at the University at Albany School of Public Health in 2010, and in addition to research on barriers to human papillomavirus vaccine uptake, he has also conducted research on vaccine mandate exemptions and the safety and effectiveness of immunization for pregnant women.
Dr. Robert Bednarczyk, PhD and Dr. Nicola Klein, MD
Nicola P. Klein, MD, PhD, is a research scientist at the Kaiser Permanente Northern California Division of Research; co-director of the Kaiser Permanente Vaccine Study Center; and clinical instructor in the Department of Pediatrics, Lucile Salter Packard Children’s Hospital at Stanford, Stanford University School of Medicine. Dr. Klein received her medical and doctorate degrees at New York University School of Medicine. Robert A. Bednarczyk, PhD, is a Clinical Investigator with Kaiser Permanente Center for Health Research – Southeast and an Epidemiologist with the Hubert Department of Global Health, Rollins School of Public Health, Emory University. Dr. Bednarczyk completed his PhD in infectious disease epidemiology at the University at Albany School of Public Health in 2010, and in addition to research on barriers to human papillomavirus vaccine uptake, he has also conducted research on vaccine mandate exemptions and the safety and effectiveness of immunization for pregnant women.